Generic Effexor XR Approved

To treat major depressive disorder

TUESDAY, June 29 (HealthDay News) -- The first generic version of Effexor extended release capsules (venlafaxine hydrochloride) to treat major depressive disorder has been approved by the U.S. Food and Drug Administration.

Prescribing information for the generic version of Effexor XR may differ from that of the brand name drug because of various patents held by the brand name drug's maker, Wyeth Pharmaceuticals, the FDA said in a news release. But the same safety warnings will apply.

Advertisement

Related Stories • Freedom More Important to Happiness Than Wealth, Study Finds • Weight-Loss Surgery Can Be Effective Despite Depression • Sleep-Deprived Teens May Crave Carbohydrates Related Videos PTSD: The War Within Women Magnets Relieve Depression Sex - The New Crack? Related Slides Depression Related Encyclopedia • Depression (Major Depressive Disorder) • Dysthymia • Seasonal Affective Disorder

The generic version will be manufactured by Teva Pharmaceuticals, based in Wales, Penn.

The drug's label includes a warning that antidepressants may raise the risk of suicidal thoughts or tendencies among some children, teens and young adults, the agency said.

More information

To learn more about this drug, visit the U.S. National Library of Medicine.

-- Scott Roberts